Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center

期刊论文
发表日期：

2024年6月14日

查看全文

Ignacio Fuentes,
Roberto Santana,
Martin Espinoza,
Eugenio Arteaga,
Thomas Uslar,
Rene Baudrand,
Gilberto González,
Francisco J. Guarda,
Nicole Lustig,
Lorena Mosso,
Flavia Nilo,
Felipe Valenzuela,
Francisco Domínguez,
Hernán Eugenio González,
Pablo H. Montero,
Francisco Cruz,
Antonieta Solar,
José M. Domínguez

摘要

Purpose

Thyroid lobectomy (TL) is an appropriate treatment for up to 4 cm intrathyroidal differentiated thyroid cancer (DTC). There is scarce data regarding TL outside first-world centers. Our aim is to report a cohort of patients with DTC treated with TL in Chile.

Methods

We included DTC patients treated with TL, followed for at least 6 months, characterized their clinicopathological features and classified their risk of recurrence and response to treatment.

Results

Eighty-two patients followed for a median of 2.3 years (0.5–7.0). Seventy-three (89%) patients had papillary, 8 (9.8%) follicular and 1 (1.2%) high-grade DTC. The risk of recurrence was low in 56 (68.3%) and intermediate in 26 (31.7%). Eight (9.8%) patients required early completion thyroidectomy and radioiodine. At last follow-up, 52 (70.3%) had excellent, 19 (25.7%) had indeterminate, and 1 (1.4%) had structural incomplete response.

Conclusion

In a developing country, TL is an adequate option for appropriately selected DTC patients.